Bio-Rad Laboratories, Inc. (FRA:BUW)

Market Cap	7.41B
Revenue (ttm)	2.18B
Net Income (ttm)	-576.07M
Shares Out	n/a
EPS (ttm)	-20.93
PE Ratio	n/a
Forward PE	30.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	230.00
Previous Close	230.00
Day's Range	230.00 - 230.00
52-Week Range	206.00 - 332.00
Beta	n/a
RSI	58.09
Earnings Date	Feb 13, 2026

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science e...

• Industry: Laboratory Analytical Instruments
• Founded: 1952
• Employees: 7,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BUW

Financial Performance

In 2024, Bio-Rad Laboratories's revenue was $2.57 billion, a decrease of -3.92% compared to the previous year's $2.67 billion. Losses were -$1.84 billion, 189.4% more than in 2023.

Financial numbers in USD